RE:When you know, you know. And I'll share what I know.I love RVV. It's a great stock in my option with vast amount of intelligent people behind.
1.) - Yes. Martin Shkreli jacked up the price on these pills. I'd wager many patients/doctors would be willing to switch over due to this (to another brand).
2.) - Yes. Always good to have politics on our side :)
3.) - Yup, there's something in the works with InMed. Keep in mind we're waaay ahead of them in terms of research/pipeline.
4.) - Yup.
5.) - I know they received good results for the gout trials but I don't think they have a JV yet. They're waiting for one to come to them.
Revive Thera is a great way to play these grassroots biotech stocks. Why? Well all the above helps but I keep stressing this ...
We have a drug that's shown in Japan in the 90s with 3 clients to reduce urinary cystine!
https://link.springer.com/chapter/10.1007%2F978-1-4615-2556-1_228
Frankly, I don't care about the marijuana research (it is great for news and "sex" appeal as DD says) but they're so much friggin' potential in Bucillamine!!!